The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey
Abstract
Authors
B. Marmarali O. Ozdemir K. Bozkurt M. Demir B. Ince H. Kultursay G. Ongen Z. Ongen C. Deger M.O. Ozel E. Parali F. Sumer E. Tuna Z.S. Yilmaz